Regulating tumor suppressor genes: post-translational modifications

L Chen, S Liu, Y Tao - Signal transduction and targeted therapy, 2020 - nature.com
Tumor suppressor genes cooperate with each other in tumors. Three important tumor
suppressor proteins, retinoblastoma (Rb), p53, phosphatase, and tensin homolog deleted …

Non‐coding RNAs in cancer immunotherapy: Predictive biomarkers and targets

M Alahdal, E Elkord - Clinical and translational medicine, 2023 - Wiley Online Library
Background To date, standardising clinical predictive biomarkers for assessing the response
to immunotherapy remains challenging due to variations in personal genetic signatures …

CircIL4R activates the PI3K/AKT signaling pathway via the miR-761/TRIM29/PHLPP1 axis and promotes proliferation and metastasis in colorectal cancer

T Jiang, H Wang, L Liu, H Song, Y Zhang, J Wang… - Molecular Cancer, 2021 - Springer
Background Accumulating studies have revealed that aberrant expression of circular RNAs
(circRNAs) is widely involved in the tumorigenesis and progression of malignant cancers …

circPTEN1, a circular RNA generated from PTEN, suppresses cancer progression through inhibition of TGF-β/Smad signaling

L Zheng, H Liang, Q Zhang, Z Shen, Y Sun, X Zhao… - Molecular cancer, 2022 - Springer
Background PTEN is one of the most frequently mutated genes in human cancer. Although
the roles of canonical PTEN protein and PTEN isoforms have been extensively explored, the …

MicroRNA-mediated autophagy regulation in cancer therapy: the role in chemoresistance/chemosensitivity

M Ashrafizadeh, A Zarrabi, S Orouei… - European Journal of …, 2021 - Elsevier
Chemoresistance has doubled the effort needed to reach an effective treatment for cancer.
Now, scientists should consider molecular pathways and mechanisms involved in …

Comprehensive characterization of PTEN mutational profile in a series of 34,129 colorectal cancers

IG Serebriiskii, V Pavlov, R Tricarico… - Nature …, 2022 - nature.com
Loss of expression or activity of the tumor suppressor PTEN acts similarly to an activating
mutation in the oncogene PIK3CA in elevating intracellular levels of phosphatidylinositol (3 …

Colorectal cancer: from genetic landscape to targeted therapy

M El Bali, J Bakkach, M Bennani Mechita - Journal of Oncology, 2021 - Wiley Online Library
Colorectal cancer (CRC) is the third most common cancer type and the second cause of
death worldwide. The advancement in understanding molecular pathways involved in CRC …

PTEN: What we know of the function and regulation of this onco-suppressor factor in bladder cancer?

M Ashrafizadeh, A Zarrabi, S Samarghandian… - European Journal of …, 2020 - Elsevier
Bladder cancer accounts for high morbidity and mortality around the world and its incidence
rate is suggested to be higher in following years. A number of factors involve in bladder …

Mutant APC promotes tumor immune evasion via PD-L1 in colorectal cancer

B Cen, J Wei, D Wang, Y Xiong, JW Shay, RN DuBois - Oncogene, 2021 - nature.com
PD-L1 expression is elevated in various human cancers, including colorectal cancer. High
levels of PD-L1 expressed on tumor epithelial cells are one of the potential mechanisms by …

Epidermal growth factor receptor targeting in colorectal carcinoma: antibodies and patient-derived organoids as a smart model to study therapy resistance

S Tardito, S Matis, MR Zocchi, R Benelli… - International Journal of …, 2024 - mdpi.com
Colorectal cancer (CRC) is the second leading cause of cancer-related death worldwide.
Therefore, the need for new therapeutic strategies is still a challenge. Surgery and …